Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors
Science Advances · 29.09.2023 · 9 (39)
DOI: 10.1126/sciadv.add9668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 29.09.2023. Verfasst von Samantha E Hoffman und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Intestinal Neoplasms, Stomach Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Neuroendocrine tumors (NETs) are rare cancers that most often arise in the gastrointestinal tract and pancreas. The fundamental mechanisms driving gastroenteropancreatic (GEP)–NET growth remain incompletely elucidated; however, the heterogeneous clinical behavior of GEP-NETs suggests that both cellular lineage dynamics and tumor microenvironment influence tumor pathophysiology. Here, we investigated the single-cell transcriptomes of tumor and immune cells from patients with gastroenteropancreatic NETs. Malignant GEP-NET cells expressed genes and regulons associated with normal, gastrointestinal endocrine cell differentiation, and fate determination stages. Tumor and lymphoid compartments sparsely expressed immunosuppressive targets commonly investigated in clinical trials, such as the programmed cell death protein–1/programmed death ligand–1 axis. However, infiltrating myeloid cell types within both primary and metastatic GEP-NETs were enriched for genes encoding other immune checkpoints, including VSIR (VISTA), HAVCR2 (TIM3), LGALS9 (Gal-9), and SIGLEC10 . Our findings highlight the transcriptomic heterogeneity that distinguishes the cellular landscapes of GEP-NET anatomic subtypes and reveal potential avenues for future precision medicine therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
- Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
- Harvard-MIT MD-PhD Program, Harvard Medical School, Boston, MA 02115, USA.
- PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
- Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.
- Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
ORCID-Profile: Samantha E Hoffman, Todd W Dowrey, Breanna Titchen, Shreya Johri, Sara Napolitano, Isaac Wakiro, Jingyi Wu, Jason Yeung, Ewa Sicinska, Naomi R Besson, Kathleen L Pfaff, Scott Rodig, Jason L Hornick, Sebastien Vigneau, Jihye Park, Matthew H Kulke, Jennifer Chan, Eliezer M Van Allen, George J Murphy
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Hoffman, S. E., Dowrey, T. W., Villacorta Martin, C., Bi, K., Titchen, B., Johri, S., DelloStritto, L., Patel, M., Mackichan, C., Inga, S., Chen, J., Grimaldi, G., Napolitano, S., Wakiro, I., Wu, J., Yeung, J., Rotem, A., Sicinska, E., Shannon, E., …, & Murphy, G. J. (2023). Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. Science Advances, 9(39). https://doi.org/10.1126/sciadv.add9668
Vancouver
Hoffman SE, Dowrey TW, Villacorta Martin C, Bi K, Titchen B, Johri S, et al. Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. Science Advances. 2023;9(39). doi:10.1126/sciadv.add9668
BibTeX
@article{Hoffman2023,
author = {Hoffman, Samantha E and Dowrey, Todd W and Villacorta Martin, Carlos and Bi, Kevin and Titchen, Breanna and Johri, Shreya and DelloStritto, Laura and Patel, Miraj and Mackichan, Colin and Inga, Stephanie and Chen, Judy and Grimaldi, Grace and Napolitano, Sara and Wakiro, Isaac and Wu, Jingyi and Yeung, Jason and Rotem, Asaf and Sicinska, Ewa and Shannon, Erin and Clancy, Thomas and Wang, Jiping and Denning, Sarah and Brais, Lauren and Besson, Naomi R and Pfaff, Kathleen L and Huang, Ying and Kao, Katrina Z and Rodig, Scott and Hornick, Jason L and Vigneau, Sebastien and Park, Jihye and Kulke, Matthew H and Chan, Jennifer and Van Allen, Eliezer M and Murphy, George J},
title = {Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {39},
doi = {10.1126/sciadv.add9668}
}
EUVIMED